AbCellera Biologics Inc (ABCL): Insights At A Glance
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $2.69, with 3.09 million shares of worth about $8.32 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -44.88% during that period and on September 11, 2024 the price saw a […]
Assessing Whether AbCellera Biologics Inc (NASDAQ: ABCL) Is Over- Or Undervalued
AbCellera Biologics Inc (ABCL) concluded trading on Thursday at a closing price of $2.53, with 2.39 million shares of worth about $6.05 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -49.90% during that period and on August 29, 2024 the price saw a […]
Better Times Ahead For AbCellera Biologics Inc (NASDAQ: ABCL)?
AbCellera Biologics Inc (ABCL) concluded trading on Thursday at a closing price of $2.51, with 2.45 million shares of worth about $6.16 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -48.25% during that period and on August 22, 2024 the price saw a […]
AbCellera Biologics Inc (NASDAQ: ABCL) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 290.82M common shares owned by the public and among those 206.32M shares have been available to trade. The company’s stock has a 5-day price change of 1.44% and -37.19% over the past three months. ABCL shares are trading -50.61% year to date (YTD), with the 12-month market performance down to -56.68% lower. […]
Technical Outlook And Game Plan For AbCellera Biologics Inc (NASDAQ: ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Thursday at a closing price of $2.94, with 3.32 million shares of worth about $9.76 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -44.74% during that period and on June 20, 2024 the price saw a […]
AbCellera Biologics Inc (NASDAQ: ABCL) Stock In Prove Me State
Baker Bros. Advisors LP has recently announced that it has increased stake in AbCellera Biologics Inc (NASDAQ:ABCL) by 26.22%. After grabbing 20.76 million shares, the institutional investor is now in possession of 4.31 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.18% having worth around $85.34 million. […]
